• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Helper
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees for your businessNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Obagi Medical Announces the Launch of Latest Innovations in The SUZANOBAGIMD® Collection

    2/10/25 9:00:00 AM ET
    $WALD
    Package Goods/Cosmetics
    Consumer Discretionary
    Get the next $WALD alert in real time by email

    2.Social Reveal _1_1080x1920

    NEW YORK, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Obagi Medical ("Obagi"), a leader in advanced skincare innovation and the originator of medical-grade skincare, proudly unveils the latest groundbreaking additions to its highly regarded SUZANOBAGIMD® collection. The new products - Super Antioxidant Serum and Moisture Restore Hydration Replenishing Cream - offer cutting-edge solutions to address common skincare concerns such as skin discoloration and brightening, oxidative stress, and skin hydration to maintain a healthy skin barrier function. Formulated to be safe and effective for all skin types—whether sensitive, oily, dry, or somewhere in between—Obagi's inclusive approach ensures that everyone can experience the benefits of advanced skincare, no matter their unique needs or concerns.

    Developed by Dr. Suzan Obagi, a distinguished dermatologist and the Chief Medical Director at Obagi, the powerhouse duo of skincare solutions reflects her extensive research and expertise in dermatologic surgery and skin health. Her expertise in formulation is drawn from her extensive experience treating thousands of patients each year, addressing a wide range of concerns. The most common issues she observes are hyperpigmentation and challenges with sensitive skin. Dr. Obagi's groundbreaking work, especially in understanding the unique needs of skin of color and the needs of sensitive skin types, led her to identify the five key pathways essential for optimal skin health. These pathways include reducing pigment formation and visibly improving hyperpigmentation, calming redness and reducing skin irritation, combating oxidative stress, supporting cell turnover, and restoring the skin barrier. Dr. Obagi has created effective products that do not irritate the skin while delivering results you can see in as little as a few weeks in some cases.

    Dr. Suzan Obagi, Chief Medical Director at Obagi, commented, "I am so excited to finally share these groundbreaking innovations with the world. These products are the culmination of years of research and patient testing, driven by my passion for helping patients unveil their naturally radiant skin without irritation. By incorporating cutting-edge ingredients like encapsulated silymarin to protect against oxidative stress and multi-weight hyaluronic acids for multi-layered hydration, we've developed solutions that truly push the envelope in skincare. I genuinely believe these novel formulations not only set a new standard but also reflect my unwavering commitment to treating skin holistically, ensuring health, resilience, and a luminous glow for every skin type."

    Drawing on this wealth of expertise in treating skin discoloration, Dr. Obagi formulated these latest additions to her namesake collection to transform skin health and deliver a radiant, brighter complexion. The collection includes the new Super Antioxidant Serum, providing medical-grade defense against oxidative stress for more resilient, radiant and youthful-looking skin. Super Antioxidant Serum is formulated with a potent blend of antioxidants, including encapsulated Silymarin and stabilized Vitamin C, to neutralize free radicals, combat oxidative stress, and brighten skin.

    Moisture Restore Hydration Replenishing Cream is a medical-grade, multi-layered moisturizer which delivers intense, multi-layered hydration. With a blend of both low and high-molecular-weight Hyaluronic Acids this cream delivers moisture to different layers of the skin.

    Delivering both immediate and long-lasting results, these products were clinically tested by Dr. Obagi and third party clinical graders. During testing of Super Antioxidant Serum and Moisture Restore Hydration Replenishing Cream, 94% of subjects felt their skin was refreshed and smoother immediately after a single application* and 97% of subjects observed an improvement in overall skin appearance after 2 weeks* including:

    • Visible improvement in the appearance of fine lines
    • Visible improvement in the appearance of hyperpigmentation
    • Visibly calms irritation and boosts hydration

    Justin Giouzepis, Chief Marketing Officer of Obagi, added, "We're thrilled to partner with Dr. Suzan Obagi on bringing to market Super Antioxidant Serum and Moisture Restore, products designed to address the critical needs of both skin brightening and hydration. Obagi is the leader in innovating products that defend against environmental aggressors with our vitamin C collection and products that treat hyperpigmentation with the Obagi Nu-Derm® collection. Having Super Antioxidant Serum in the Obagi portfolio provides professionals with an additional oxidative stress fighting product to recommend to their patients who may have sensitive skin but don't want to compromise on results. We know achieving radiant, healthy skin shouldn't come at the cost of irritation, which is why we've prioritized gentle yet effective formulations suitable for even the most sensitive skin types. These launches represent our commitment to providing inclusive skincare solutions for everyone."

    The SUZANOBAGIMD® Super Antioxidant Serum, priced at $158, and the SUZANOBAGIMD® Moisture Restore Hydration Replenishing Cream, priced at $78, are now available through partnering professional channels. They will be available for customers to purchase on Obagi.com on 2.24.2025.

    *Results are based on a 2024 2-week clinical test, with subjects using SOMD Super Antioxidant Serum & Moisture Restore Replenishing Cream (if needed) daily within protocol.

    About Obagi Medical

    Obagi Medical is an industry-leading, advanced skincare line rooted in research and skin biology, refined with a legacy of 35 years' experience. First known as leaders in the treatment of hyperpigmentation with the Obagi Nu-Derm® System, Obagi products are designed to diminish the appearance of premature aging, photodamage, skin discoloration, acne, and sun damage. Backed by science and trusted by professionals, Obagi empowers individuals to achieve healthy, beautiful skin.

    More information about Obagi is available on the brand's website, https://www.obagi.com.

    About Waldencast

    Founded by Michel Brousset and Hind Sebti, Waldencast's ambition is to build a global best-in-class beauty and wellness operating platform by developing, acquiring, accelerating, and scaling conscious, high-growth purpose-driven brands. Waldencast's vision is fundamentally underpinned by its brand-led business model that ensures proximity to its customers, business agility, and market responsiveness, while maintaining each brand's distinct DNA. The first step in realizing its vision was the business combination with Obagi Cosmeceuticals and Milk Makeup. As part of the Waldencast platform, its brands will benefit from the operational scale of a multi-brand platform; the expertise in managing global beauty brands at scale; a balanced portfolio to mitigate category fluctuations; asset-light efficiency; and the market responsiveness and speed of entrepreneurial indie brands. For more information please visit: https://ir.waldencast.com/.

    Media Contact:

    [email protected]

    A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/2e3ff584-7c90-4039-9b0e-ab93ef0fcf5a



    Primary Logo

    Get the next $WALD alert in real time by email

    Crush Q3 2025 with the Best AI Executive Assistant

    Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Tailforce.ai

    Recent Analyst Ratings for
    $WALD

    DatePrice TargetRatingAnalyst
    4/22/2025$5.00Buy
    Alliance Global Partners
    12/16/2024$4.30Hold
    TD Cowen
    10/25/2024$5.00Buy
    Canaccord Genuity
    5/1/2024$10.00 → $8.00Outperform
    Telsey Advisory Group
    7/24/2023Outperform → Mkt Perform
    Raymond James
    9/9/2022$12.00Buy
    DA Davidson
    8/22/2022$11.00Outperform
    Raymond James
    8/17/2022$11.00Buy
    Jefferies
    More analyst ratings

    $WALD
    SEC Filings

    See more
    • SEC Form 6-K filed by Waldencast plc

      6-K - Waldencast plc (0001840199) (Filer)

      7/23/25 6:50:54 AM ET
      $WALD
      Package Goods/Cosmetics
      Consumer Discretionary
    • SEC Form 6-K filed by Waldencast plc

      6-K - Waldencast plc (0001840199) (Filer)

      5/14/25 7:00:36 AM ET
      $WALD
      Package Goods/Cosmetics
      Consumer Discretionary
    • SEC Form 6-K filed by Waldencast plc

      6-K - Waldencast plc (0001840199) (Filer)

      5/13/25 4:05:31 PM ET
      $WALD
      Package Goods/Cosmetics
      Consumer Discretionary

    $WALD
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Alliance Global Partners initiated coverage on Waldencast plc with a new price target

      Alliance Global Partners initiated coverage of Waldencast plc with a rating of Buy and set a new price target of $5.00

      4/22/25 9:24:54 AM ET
      $WALD
      Package Goods/Cosmetics
      Consumer Discretionary
    • TD Cowen initiated coverage on Waldencast plc with a new price target

      TD Cowen initiated coverage of Waldencast plc with a rating of Hold and set a new price target of $4.30

      12/16/24 6:40:14 AM ET
      $WALD
      Package Goods/Cosmetics
      Consumer Discretionary
    • Canaccord Genuity initiated coverage on Waldencast plc with a new price target

      Canaccord Genuity initiated coverage of Waldencast plc with a rating of Buy and set a new price target of $5.00

      10/25/24 7:48:31 AM ET
      $WALD
      Package Goods/Cosmetics
      Consumer Discretionary

    $WALD
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4 filed by Waldencast Long-Term Capital Llc

      4 - Waldencast Acquisition Corp. (0001840199) (Issuer)

      7/25/22 12:43:24 PM ET
      $WALD
      Package Goods/Cosmetics
      Consumer Discretionary
    • SEC Form 3 filed by new insider Festetics Tassilo

      3 - Waldencast Acquisition Corp. (0001840199) (Issuer)

      3/7/22 5:00:12 PM ET
      $WALD
      Package Goods/Cosmetics
      Consumer Discretionary
    • SEC Form 3 filed by new insider Chatterley Aaron

      3 - Waldencast Acquisition Corp. (0001840199) (Issuer)

      12/23/21 4:30:38 PM ET
      $WALD
      Package Goods/Cosmetics
      Consumer Discretionary

    $WALD
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Waldencast Acquires Novaestiq Corp. and U.S. Rights to Leading Injectable Hyaluronic Acid Gel Line, Saypha®, Under the Obagi Medical Brand

      Acquisition strengthens Obagi Medical's product portfolio with proven, scientifically backed, injectable portfolio New products position Obagi Medical at the forefront of health, beauty and aesthetics convergence LONDON, July 23, 2025 (GLOBE NEWSWIRE) -- Waldencast plc (NASDAQ:WALD) ("Waldencast"), a global multi-brand beauty and wellness platform, today announced that it has acquired Novaestiq Corp. (Novaestiq), a growth-oriented aesthetic and medical dermatological innovations company, as well as the U.S. rights to the Saypha® line of hyaluronic acid (HA) injectable gels. The strategic acquisition expands Obagi Medical's offerings beyond U.S. medical-grade skincare, a marke

      7/23/25 6:45:00 AM ET
      $WALD
      Package Goods/Cosmetics
      Consumer Discretionary
    • Shareholders Elect Four Independent Directors to the Six Flags Board

      Six Flags Entertainment Corporation (NYSE:FUN), the largest regional amusement park operator in North America, announced today that its shareholders elected Sandra (Sandy) Cochran, Michael Colglazier, Felipe Dutra, and Steven Hoffman to the Board of Directors of Six Flags Entertainment Corporation for 3-year terms expiring in 2028. Shareholders also confirmed the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm, approved an advisory vote on the compensation of the Company's named executive officers, and confirmed a 1-year frequency for shareholder advisory votes on executive compensation. "I want to welcome Sandy, Michael, Felipe and St

      6/25/25 5:00:00 PM ET
      $BUD
      $CBRL
      $DG
      $FUN
      Beverages (Production/Distribution)
      Consumer Staples
      Restaurants
      Consumer Discretionary
    • Waldencast Reports Q1 2025 Financial Results

      Q1 Net Revenue of $65.4 million, (4.1)% decline from Q1 202476.4% Adjusted Gross Margin, an improvement of 10 basis points$4.4 million of Adjusted EBITDA LONDON, May 13, 2025 (GLOBE NEWSWIRE) -- Waldencast plc (NASDAQ:WALD) ("Waldencast" or the "Company"), a global multi-brand beauty and wellness platform, today reported operating results for the three months ended March 31, 2025 ("Q1 2025") on Form 6-K to the U.S. Securities and Exchange Commission (the "SEC"), which are also available on our investor relations site at http://ir.waldencast.com/. Michel Brousset, Waldencast Founder and CEO, said: "As anticipated, in Q1 2025, Milk Makeup results were impacted by the cycling of the very su

      5/13/25 4:15:00 PM ET
      $WALD
      Package Goods/Cosmetics
      Consumer Discretionary

    $WALD
    Leadership Updates

    Live Leadership Updates

    See more
    • Shareholders Elect Four Independent Directors to the Six Flags Board

      Six Flags Entertainment Corporation (NYSE:FUN), the largest regional amusement park operator in North America, announced today that its shareholders elected Sandra (Sandy) Cochran, Michael Colglazier, Felipe Dutra, and Steven Hoffman to the Board of Directors of Six Flags Entertainment Corporation for 3-year terms expiring in 2028. Shareholders also confirmed the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm, approved an advisory vote on the compensation of the Company's named executive officers, and confirmed a 1-year frequency for shareholder advisory votes on executive compensation. "I want to welcome Sandy, Michael, Felipe and St

      6/25/25 5:00:00 PM ET
      $BUD
      $CBRL
      $DG
      $FUN
      Beverages (Production/Distribution)
      Consumer Staples
      Restaurants
      Consumer Discretionary
    • Milk Makeup to Launch at Ulta Beauty This Spring

      The New York City based award-winning clean color cosmetics brand will expand to select Ulta Beauty stores nationwide and online, marking a significant milestone since its debut in 2016 NEW YORK, Jan. 28, 2025 /PRNewswire/ -- Milk Makeup, the trailblazing clean beauty brand celebrated for its iconic, high-performance formulas, inclusive ethos and part of the Waldencast plc (NASDAQ:WALD) platform, is thrilled to announce an expansion into the nation's largest beauty retailer, Ulta Beauty. Beginning this spring, Milk Makeup's cult-favorite products, including the 13x award-winning Hydro Grip Primer and internet-breaking Cooling Water Jelly Tints will be available in 600+ Ulta Beauty stores nat

      1/28/25 6:45:00 AM ET
      $WALD
      Package Goods/Cosmetics
      Consumer Discretionary
    • Waldencast Announces New "Creative Council" of Industry Pioneers and Disruptors

      NEW YORK, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Waldencast plc, (NASDAQ:WALD) ("Waldencast" or "the Company"), a global multi-brand beauty and wellness platform, today announced the formation of a new Creative Council. The interdisciplinary team of industry disruptors will come together to help Waldencast stay ahead of the curve by ideating on long-term macro and micro-trends in the beauty and wellness industry, and to ensure the Company evolves to meet customer needs now and in the future. The Creative Council will focus on what is next in beauty, wellness, and culture. The goal of the powerhouse group is to provide a pulse on trends and become the dreamers and makers of what these industrie

      2/22/24 9:15:00 AM ET
      $WALD
      Package Goods/Cosmetics
      Consumer Discretionary

    $WALD
    Financials

    Live finance-specific insights

    See more
    • Waldencast Acquires Novaestiq Corp. and U.S. Rights to Leading Injectable Hyaluronic Acid Gel Line, Saypha®, Under the Obagi Medical Brand

      Acquisition strengthens Obagi Medical's product portfolio with proven, scientifically backed, injectable portfolio New products position Obagi Medical at the forefront of health, beauty and aesthetics convergence LONDON, July 23, 2025 (GLOBE NEWSWIRE) -- Waldencast plc (NASDAQ:WALD) ("Waldencast"), a global multi-brand beauty and wellness platform, today announced that it has acquired Novaestiq Corp. (Novaestiq), a growth-oriented aesthetic and medical dermatological innovations company, as well as the U.S. rights to the Saypha® line of hyaluronic acid (HA) injectable gels. The strategic acquisition expands Obagi Medical's offerings beyond U.S. medical-grade skincare, a marke

      7/23/25 6:45:00 AM ET
      $WALD
      Package Goods/Cosmetics
      Consumer Discretionary
    • Waldencast Reports Q1 2025 Financial Results

      Q1 Net Revenue of $65.4 million, (4.1)% decline from Q1 202476.4% Adjusted Gross Margin, an improvement of 10 basis points$4.4 million of Adjusted EBITDA LONDON, May 13, 2025 (GLOBE NEWSWIRE) -- Waldencast plc (NASDAQ:WALD) ("Waldencast" or the "Company"), a global multi-brand beauty and wellness platform, today reported operating results for the three months ended March 31, 2025 ("Q1 2025") on Form 6-K to the U.S. Securities and Exchange Commission (the "SEC"), which are also available on our investor relations site at http://ir.waldencast.com/. Michel Brousset, Waldencast Founder and CEO, said: "As anticipated, in Q1 2025, Milk Makeup results were impacted by the cycling of the very su

      5/13/25 4:15:00 PM ET
      $WALD
      Package Goods/Cosmetics
      Consumer Discretionary
    • Waldencast plc Announces First Quarter Fiscal 2025 Results Conference Call and Webcast

      LONDON, May 06, 2025 (GLOBE NEWSWIRE) -- Waldencast plc, (NASDAQ:WALD) ("Waldencast"), a global multi-brand beauty and wellness platform provided the details for its First Quarter Fiscal 2025 conference call and webcast. As previously announced, the Company will issue its First Quarter Fiscal 2025 results on May 13, 2025 after the close of the U.S. market. Management will host a conference call to discuss its First Quarter Fiscal 2025 results on May 14, 2025 at 8:30am ET. Investors and analysts interested in participating in the conference call are invited to dial (877) 704-4453 or (201) 389-0920 for international callers. The conference call will be webcast live and include a slide p

      5/6/25 4:05:49 PM ET
      $WALD
      Package Goods/Cosmetics
      Consumer Discretionary

    $WALD
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13D/A filed by Waldencast plc (Amendment)

      SC 13D/A - Waldencast plc (0001840199) (Subject)

      2/9/24 6:25:08 PM ET
      $WALD
      Package Goods/Cosmetics
      Consumer Discretionary
    • SEC Form SC 13G filed by Waldencast plc

      SC 13G - Waldencast plc (0001840199) (Subject)

      2/1/24 5:17:40 PM ET
      $WALD
      Package Goods/Cosmetics
      Consumer Discretionary
    • SEC Form SC 13G/A filed by Waldencast plc (Amendment)

      SC 13G/A - Waldencast plc (0001840199) (Subject)

      1/31/24 10:23:25 AM ET
      $WALD
      Package Goods/Cosmetics
      Consumer Discretionary